Dioseve is a biotechnology company that produces egg cells using DIOLs to create more life possiblities.
Dioseve has raised $6.2M in total funding. The most recent round was Series A. The last funding was announced in June 2026.
Dioseve's investors include Shionogi venture, ANRI, Pangaea Ventures, Coral Capital, Spiral Capital.
Dioseve is headquartered in Tokyo, Japan.
Dioseve is a biotechnology company that produces egg cells using DIOLs to create more life possiblities.
Dioseve is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Dioseve — Funding & Investors." VCBacked, June 11, 2026, https://www.vcbacked.co/company/dioseve. Accessed July 20, 2026.
VCBacked. (2026). Dioseve — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/dioseve
{{cite web |title=Dioseve — Funding & Investors |url=https://www.vcbacked.co/company/dioseve |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated